[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"typ-2-diabetes\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:typ-2-diabetes":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,46],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":29,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":4},"100638054","concurrent-exercise-training-100638054",false,"NCT07630025","Concurrent Exercise Training","The Impact of Morning Versus Evening Concurrent High-Intensity Interval Training and Resistance Training on Glycemic Control in in Men With Type 2 Diabetes Mellitus: A Randomized Controlled Trial","T2D","Inclusion Criteria:\n\n* men aged 40-60 years with a diagnosis of T2D\n* HbA1c levels between 7.0% and 9.0%\n* treatment with oral hypoglycemic agents for at least 6 months\n* a BMI \\\u003C30 kg\u002Fm²\n* a physically inactive\n\nExclusion Criteria:\n\n* current insulin therapy\n* a cardiovascular event within the previous 6 months\n* cardiovascular, respiratory or musculoskeletal conditions that could limit participation in exercise training\n* body weight instability","MALE","40 Years","60 Years",{"count":21,"type":22},60,"ESTIMATED","INTERVENTIONAL",[25],"NA","The goal of this clinical trial is to investigate the influence of morning versus evening concurrent training consisting of high-intensity interval training and resistance training on glycemic control in men with type 2 diabetes mellitus. The main questions it aims to answer are:\n\n• Which time is best for concurrent exercise training in diabetic patients, morning or evening? Researchers will compare morning versus evening concurrent training consisting of HIIT and RT on glycemic control in men with type 2 diabetes mellitus.\n\nParticipants will:\n\n* Perform concurrent training consisting of high-intensity interval training and resistance training for 12 weeks\n* Visit the clinic before and after the 12-week experimental period for checkups and tests",[28],"Typ 2 Diabetes",[30,31,32,33],"Diabetes","High Intensity Interval Trainin","resistance trsaining","glycemic control","NOT_YET_RECRUITING","2026-06-01",{"date":37,"type":38},"2026-06-05","ACTUAL",{"date":40,"type":22},"2026-06",{"date":42,"type":22},"2026-10",{"name":44,"class":45},"Prince Sattam Bin Abdulaziz University","OTHER",{"id":47,"slug":48,"hasResults":11,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":52,"eligibilityCriteria":53,"healthyVolunteers":11,"sex":54,"minAge":55,"maxAge":4,"enrollmentInfo":56,"targetDuration":4,"studyType":23,"phases":58,"briefSummary":59,"conditions":60,"keywords":64,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":78},"100625057","multicentric-approval-study-trans-duodenal-barrier-for-typ-2-diabetes-with-obesity-100625057","NCT07417683","Multicentric Approval Study Trans-Duodenal Barrier for Typ 2 Diabetes With Obesity","Leistung Und Sicherheit Des Trans-Duodenal Barrier (LuST)","LuST","Inclusion Criteria:\n\n* Obese patients with type 2 diabetes mellitus,\n* Age ≥ 18 years,\n* The patient is able to understand the nature, significance, and scope of the clinical trial (MPDG §28),\n* The patient has been informed and all written consents from the patient are available.\n\nExclusion Criteria:\n\n* The patient is mentally incapable of understanding the nature, objectives, or possible consequences of the clinical trial.\n* The patient is unwilling or unable to follow postoperative instructions.\n* The patient has been placed in an institution by court order or official order (MPDG §27).\n* The patient lives more than 100 km from the treatment site.\n* Pregnancy.\n* The patient is participating in another clinical trial in the field of diabetes management or metabolic syndrome.","ALL","18 Years",{"count":57,"type":22},126,[25],"Approval study Trans-Duodenal Barrier The goal of this clinical trial is to determin the safety and performance of the newly developed Trans-Duodenal Barrier in adult Tryp 2 diabetic and obese patients.\n\nThe Trans-Duodenal Barrier is an endoscopic implant which can be placed to the gastric outlet and the upper small bowel by interventional endoscopy. It consists of a 60 cm long foil tube , a transpyloric shaft and and two ringlike balloons to fix it at the pylorus. It will be removed after 6 months via gastroscopy.\n\nThe main questions it aims to answer are:\n\n* Does the Trans-Duodenal Barrier lower the HbA1c of the participants ?\n* How frequent are adverse side effects related to the device?\n* How much ist the excessive wight loss of treated patients ?\n* Show patients with Metabolic assiociated Hepatosteatitis (MASH) improvements in liver elasticity (elastography) ? Researchers implant the Trans-Duodenal Barrier to enclosed patients and follow up them till 4 weeks after explantation.\n\nParticipants will:\n\n* Get the Trans-Duodenal Barrier as an implant for 6 moths\n* Visit the clinic 3 times in the implant period and once for explant.\n* Receive a telefon interview 4 weeks after explant",[28,61,62,63],"Obesity","Obesity Type 2 Diabetes Mellitus","MASH",[65,66,67,33],"gastroduodenal liner","endoscopic implant","wight management","2026-02-10",{"date":70,"type":38},"2026-02-18",{"date":72,"type":22},"2026-03",{"date":74,"type":22},"2028-04",{"name":76,"class":77},"Trans-Duodenal Concepts GmbH","INDUSTRY",8]